Konan Medical Receives FDA 510(k) Approval for its objectiveFIELD Device

 Konan Medical Receives FDA 510(k) Approval for its objectiveFIELD Device

Konan Medical Receives FDA 510(k) Approval for its objectiveFIELD Device

Shots:

  • Konan acquired objectiveFIELD Device from Australian National University (ANU) including 15 issued patents in 9 countries, 6 patients in the process, and clinical data for multiple diagnostic indications and was examined for visual-field manifestations
  • The medical device was investigated in Australia for >12 years with >1600 examinations across normal, glaucoma, macular degeneration, diabetic retinopathy, multiple sclerosis, epilepsy, migraine, concussion, and other neuro-vision disorders
  • objectiveFIELD is a novel, FDA approved human visual field device used to test both the eyes simultaneously in minutes with no manual efforts, using multi-focal pupil objective perimetry method (mfPOP)

Click here to read full press release/ article | Ref: Konan Medicals | Image: Compelo

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post